nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—Erlotinib—pancreatic cancer	0.139	0.361	CbGbCtD
Auranofin—ALB—Irinotecan—pancreatic cancer	0.126	0.326	CbGbCtD
Auranofin—ALB—Fluorouracil—pancreatic cancer	0.121	0.313	CbGbCtD
Auranofin—PRDX5—islet of Langerhans—pancreatic cancer	0.00572	0.314	CbGeAlD
Auranofin—PRDX5—pancreas—pancreatic cancer	0.00402	0.221	CbGeAlD
Auranofin—PRDX5—digestive system—pancreatic cancer	0.00344	0.188	CbGeAlD
Auranofin—Melaena—Erlotinib—pancreatic cancer	0.00339	0.011	CcSEcCtD
Auranofin—Protein urine present—Sunitinib—pancreatic cancer	0.00338	0.011	CcSEcCtD
Auranofin—Glossitis—Sunitinib—pancreatic cancer	0.00326	0.0106	CcSEcCtD
Auranofin—ALB—gall bladder—pancreatic cancer	0.00302	0.165	CbGeAlD
Auranofin—Melaena—Sunitinib—pancreatic cancer	0.00294	0.00955	CcSEcCtD
Auranofin—Proteinuria—Gemcitabine—pancreatic cancer	0.00275	0.00893	CcSEcCtD
Auranofin—Protein urine present—Gemcitabine—pancreatic cancer	0.00271	0.00881	CcSEcCtD
Auranofin—Hepatic enzyme increased—Gemcitabine—pancreatic cancer	0.00255	0.0083	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Erlotinib—pancreatic cancer	0.00252	0.0082	CcSEcCtD
Auranofin—Interstitial lung disease—Docetaxel—pancreatic cancer	0.00242	0.00787	CcSEcCtD
Auranofin—Dysphagia—Tamoxifen—pancreatic cancer	0.0022	0.00716	CcSEcCtD
Auranofin—Dysphagia—Erlotinib—pancreatic cancer	0.00218	0.00709	CcSEcCtD
Auranofin—Pancytopenia—Tamoxifen—pancreatic cancer	0.00209	0.0068	CcSEcCtD
Auranofin—Neutropenia—Tamoxifen—pancreatic cancer	0.00206	0.0067	CcSEcCtD
Auranofin—Neutropenia—Erlotinib—pancreatic cancer	0.00204	0.00663	CcSEcCtD
Auranofin—IKBKB—digestive system—pancreatic cancer	0.00203	0.112	CbGeAlD
Auranofin—Weight decreased—Tamoxifen—pancreatic cancer	0.00199	0.00648	CcSEcCtD
Auranofin—Weight decreased—Erlotinib—pancreatic cancer	0.00197	0.00641	CcSEcCtD
Auranofin—Dermatitis exfoliative—Irinotecan—pancreatic cancer	0.00191	0.0062	CcSEcCtD
Auranofin—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.00191	0.0062	CcSEcCtD
Auranofin—Stomatitis—Erlotinib—pancreatic cancer	0.00189	0.00616	CcSEcCtD
Auranofin—Conjunctivitis—Erlotinib—pancreatic cancer	0.00189	0.00614	CcSEcCtD
Auranofin—Dysphagia—Sunitinib—pancreatic cancer	0.00189	0.00614	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Irinotecan—pancreatic cancer	0.0018	0.00585	CcSEcCtD
Auranofin—Pancytopenia—Sunitinib—pancreatic cancer	0.00179	0.00583	CcSEcCtD
Auranofin—Neutropenia—Sunitinib—pancreatic cancer	0.00176	0.00574	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Fluorouracil—pancreatic cancer	0.00172	0.0056	CcSEcCtD
Auranofin—Weight decreased—Sunitinib—pancreatic cancer	0.00171	0.00555	CcSEcCtD
Auranofin—Visual impairment—Tamoxifen—pancreatic cancer	0.0017	0.00553	CcSEcCtD
Auranofin—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.00165	0.00536	CcSEcCtD
Auranofin—Stomatitis—Sunitinib—pancreatic cancer	0.00164	0.00533	CcSEcCtD
Auranofin—Eye disorder—Erlotinib—pancreatic cancer	0.00163	0.0053	CcSEcCtD
Auranofin—Alopecia—Tamoxifen—pancreatic cancer	0.00156	0.00507	CcSEcCtD
Auranofin—Alopecia—Erlotinib—pancreatic cancer	0.00154	0.00501	CcSEcCtD
Auranofin—Dysgeusia—Tamoxifen—pancreatic cancer	0.0015	0.00489	CcSEcCtD
Auranofin—Flatulence—Erlotinib—pancreatic cancer	0.0015	0.00487	CcSEcCtD
Auranofin—Dysphagia—Fluorouracil—pancreatic cancer	0.00149	0.00484	CcSEcCtD
Auranofin—Eosinophilia—Fluorouracil—pancreatic cancer	0.00147	0.00479	CcSEcCtD
Auranofin—Gingivitis—Epirubicin—pancreatic cancer	0.00147	0.00479	CcSEcCtD
Auranofin—Neutropenia—Irinotecan—pancreatic cancer	0.00145	0.00473	CcSEcCtD
Auranofin—Pancytopenia—Gemcitabine—pancreatic cancer	0.00144	0.00468	CcSEcCtD
Auranofin—Anaemia—Tamoxifen—pancreatic cancer	0.00142	0.00461	CcSEcCtD
Auranofin—Neutropenia—Gemcitabine—pancreatic cancer	0.00142	0.0046	CcSEcCtD
Auranofin—Pancytopenia—Fluorouracil—pancreatic cancer	0.00141	0.0046	CcSEcCtD
Auranofin—Eye disorder—Sunitinib—pancreatic cancer	0.00141	0.00459	CcSEcCtD
Auranofin—Weight decreased—Irinotecan—pancreatic cancer	0.00141	0.00457	CcSEcCtD
Auranofin—Angioedema—Tamoxifen—pancreatic cancer	0.0014	0.00456	CcSEcCtD
Auranofin—Leukopenia—Tamoxifen—pancreatic cancer	0.00137	0.00447	CcSEcCtD
Auranofin—Gingivitis—Doxorubicin—pancreatic cancer	0.00136	0.00443	CcSEcCtD
Auranofin—Jaundice—Irinotecan—pancreatic cancer	0.00135	0.00439	CcSEcCtD
Auranofin—Stomatitis—Irinotecan—pancreatic cancer	0.00135	0.00439	CcSEcCtD
Auranofin—Alopecia—Sunitinib—pancreatic cancer	0.00133	0.00434	CcSEcCtD
Auranofin—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.00132	0.0043	CcSEcCtD
Auranofin—Stomatitis—Gemcitabine—pancreatic cancer	0.00132	0.00428	CcSEcCtD
Auranofin—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.0013	0.00423	CcSEcCtD
Auranofin—Flatulence—Sunitinib—pancreatic cancer	0.0013	0.00421	CcSEcCtD
Auranofin—Stomatitis—Fluorouracil—pancreatic cancer	0.00129	0.00421	CcSEcCtD
Auranofin—Conjunctivitis—Fluorouracil—pancreatic cancer	0.00129	0.0042	CcSEcCtD
Auranofin—Dysgeusia—Sunitinib—pancreatic cancer	0.00129	0.00419	CcSEcCtD
Auranofin—Haematuria—Gemcitabine—pancreatic cancer	0.00129	0.00419	CcSEcCtD
Auranofin—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00126	0.0041	CcSEcCtD
Auranofin—Glossitis—Epirubicin—pancreatic cancer	0.00125	0.00408	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.00124	0.00404	CcSEcCtD
Auranofin—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00124	0.00403	CcSEcCtD
Auranofin—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00123	0.00399	CcSEcCtD
Auranofin—Anaemia—Sunitinib—pancreatic cancer	0.00122	0.00395	CcSEcCtD
Auranofin—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00121	0.00395	CcSEcCtD
Auranofin—Angioedema—Sunitinib—pancreatic cancer	0.0012	0.00391	CcSEcCtD
Auranofin—Visual impairment—Irinotecan—pancreatic cancer	0.0012	0.0039	CcSEcCtD
Auranofin—Anorexia—Tamoxifen—pancreatic cancer	0.00119	0.00388	CcSEcCtD
Auranofin—Anorexia—Erlotinib—pancreatic cancer	0.00118	0.00384	CcSEcCtD
Auranofin—Leukopenia—Sunitinib—pancreatic cancer	0.00118	0.00383	CcSEcCtD
Auranofin—Glossitis—Doxorubicin—pancreatic cancer	0.00116	0.00377	CcSEcCtD
Auranofin—Melaena—Epirubicin—pancreatic cancer	0.00113	0.00367	CcSEcCtD
Auranofin—Dyspepsia—Tamoxifen—pancreatic cancer	0.0011	0.00359	CcSEcCtD
Auranofin—Alopecia—Irinotecan—pancreatic cancer	0.0011	0.00358	CcSEcCtD
Auranofin—Dyspepsia—Erlotinib—pancreatic cancer	0.00109	0.00355	CcSEcCtD
Auranofin—Decreased appetite—Tamoxifen—pancreatic cancer	0.00109	0.00354	CcSEcCtD
Auranofin—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00108	0.00353	CcSEcCtD
Auranofin—Decreased appetite—Erlotinib—pancreatic cancer	0.00108	0.0035	CcSEcCtD
Auranofin—Dysphagia—Docetaxel—pancreatic cancer	0.00107	0.00349	CcSEcCtD
Auranofin—Constipation—Tamoxifen—pancreatic cancer	0.00107	0.00348	CcSEcCtD
Auranofin—Alopecia—Gemcitabine—pancreatic cancer	0.00107	0.00348	CcSEcCtD
Auranofin—Flatulence—Irinotecan—pancreatic cancer	0.00107	0.00347	CcSEcCtD
Auranofin—Constipation—Erlotinib—pancreatic cancer	0.00106	0.00345	CcSEcCtD
Auranofin—Alopecia—Fluorouracil—pancreatic cancer	0.00105	0.00342	CcSEcCtD
Auranofin—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00105	0.00342	CcSEcCtD
Auranofin—Melaena—Doxorubicin—pancreatic cancer	0.00104	0.0034	CcSEcCtD
Auranofin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00102	0.00333	CcSEcCtD
Auranofin—Anorexia—Sunitinib—pancreatic cancer	0.00102	0.00333	CcSEcCtD
Auranofin—Pancytopenia—Docetaxel—pancreatic cancer	0.00102	0.00332	CcSEcCtD
Auranofin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00101	0.0033	CcSEcCtD
Auranofin—Neutropenia—Docetaxel—pancreatic cancer	0.001	0.00327	CcSEcCtD
Auranofin—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.001	0.00326	CcSEcCtD
Auranofin—Anaemia—Irinotecan—pancreatic cancer	0.001	0.00326	CcSEcCtD
Auranofin—Urticaria—Tamoxifen—pancreatic cancer	0.000995	0.00324	CcSEcCtD
Auranofin—Abdominal pain—Tamoxifen—pancreatic cancer	0.00099	0.00322	CcSEcCtD
Auranofin—Abdominal pain—Erlotinib—pancreatic cancer	0.00098	0.00319	CcSEcCtD
Auranofin—Anaemia—Gemcitabine—pancreatic cancer	0.000975	0.00317	CcSEcCtD
Auranofin—Weight decreased—Docetaxel—pancreatic cancer	0.000972	0.00316	CcSEcCtD
Auranofin—Leukopenia—Irinotecan—pancreatic cancer	0.000969	0.00315	CcSEcCtD
Auranofin—Anaemia—Fluorouracil—pancreatic cancer	0.000959	0.00312	CcSEcCtD
Auranofin—Dyspepsia—Sunitinib—pancreatic cancer	0.000945	0.00307	CcSEcCtD
Auranofin—Leukopenia—Gemcitabine—pancreatic cancer	0.000944	0.00307	CcSEcCtD
Auranofin—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000939	0.00305	CcSEcCtD
Auranofin—Jaundice—Docetaxel—pancreatic cancer	0.000934	0.00304	CcSEcCtD
Auranofin—Stomatitis—Docetaxel—pancreatic cancer	0.000934	0.00304	CcSEcCtD
Auranofin—Decreased appetite—Sunitinib—pancreatic cancer	0.000933	0.00303	CcSEcCtD
Auranofin—Conjunctivitis—Docetaxel—pancreatic cancer	0.000931	0.00303	CcSEcCtD
Auranofin—Leukopenia—Fluorouracil—pancreatic cancer	0.000929	0.00302	CcSEcCtD
Auranofin—Constipation—Sunitinib—pancreatic cancer	0.000918	0.00298	CcSEcCtD
Auranofin—Agranulocytosis—Docetaxel—pancreatic cancer	0.000894	0.00291	CcSEcCtD
Auranofin—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000889	0.00289	CcSEcCtD
Auranofin—Pruritus—Tamoxifen—pancreatic cancer	0.000886	0.00288	CcSEcCtD
Auranofin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000877	0.00285	CcSEcCtD
Auranofin—Pruritus—Erlotinib—pancreatic cancer	0.000877	0.00285	CcSEcCtD
Auranofin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000865	0.00281	CcSEcCtD
Auranofin—Diarrhoea—Tamoxifen—pancreatic cancer	0.000857	0.00279	CcSEcCtD
Auranofin—Abdominal pain—Sunitinib—pancreatic cancer	0.000848	0.00276	CcSEcCtD
Auranofin—Diarrhoea—Erlotinib—pancreatic cancer	0.000848	0.00276	CcSEcCtD
Auranofin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000843	0.00274	CcSEcCtD
Auranofin—Anorexia—Irinotecan—pancreatic cancer	0.000843	0.00274	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000839	0.00273	CcSEcCtD
Auranofin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000829	0.0027	CcSEcCtD
Auranofin—Visual impairment—Docetaxel—pancreatic cancer	0.000829	0.0027	CcSEcCtD
Auranofin—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000822	0.00267	CcSEcCtD
Auranofin—Anorexia—Gemcitabine—pancreatic cancer	0.000821	0.00267	CcSEcCtD
Auranofin—Anorexia—Fluorouracil—pancreatic cancer	0.000807	0.00262	CcSEcCtD
Auranofin—Eye disorder—Docetaxel—pancreatic cancer	0.000804	0.00261	CcSEcCtD
Auranofin—Vomiting—Tamoxifen—pancreatic cancer	0.000797	0.00259	CcSEcCtD
Auranofin—Rash—Tamoxifen—pancreatic cancer	0.00079	0.00257	CcSEcCtD
Auranofin—Dermatitis—Tamoxifen—pancreatic cancer	0.000789	0.00257	CcSEcCtD
Auranofin—Vomiting—Erlotinib—pancreatic cancer	0.000788	0.00256	CcSEcCtD
Auranofin—Rash—Erlotinib—pancreatic cancer	0.000782	0.00254	CcSEcCtD
Auranofin—Dermatitis—Erlotinib—pancreatic cancer	0.000781	0.00254	CcSEcCtD
Auranofin—Dyspepsia—Irinotecan—pancreatic cancer	0.000778	0.00253	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000776	0.00252	CcSEcCtD
Auranofin—Decreased appetite—Irinotecan—pancreatic cancer	0.000768	0.0025	CcSEcCtD
Auranofin—Alopecia—Docetaxel—pancreatic cancer	0.00076	0.00247	CcSEcCtD
Auranofin—Pruritus—Sunitinib—pancreatic cancer	0.000759	0.00247	CcSEcCtD
Auranofin—Constipation—Irinotecan—pancreatic cancer	0.000756	0.00246	CcSEcCtD
Auranofin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000748	0.00243	CcSEcCtD
Auranofin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000745	0.00242	CcSEcCtD
Auranofin—Nausea—Tamoxifen—pancreatic cancer	0.000744	0.00242	CcSEcCtD
Auranofin—Constipation—Gemcitabine—pancreatic cancer	0.000736	0.00239	CcSEcCtD
Auranofin—Nausea—Erlotinib—pancreatic cancer	0.000736	0.00239	CcSEcCtD
Auranofin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000736	0.00239	CcSEcCtD
Auranofin—Diarrhoea—Sunitinib—pancreatic cancer	0.000734	0.00239	CcSEcCtD
Auranofin—Dysgeusia—Docetaxel—pancreatic cancer	0.000733	0.00238	CcSEcCtD
Auranofin—Dysphagia—Epirubicin—pancreatic cancer	0.000725	0.00236	CcSEcCtD
Auranofin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000723	0.00235	CcSEcCtD
Auranofin—Eosinophilia—Epirubicin—pancreatic cancer	0.000718	0.00233	CcSEcCtD
Auranofin—Abdominal pain—Irinotecan—pancreatic cancer	0.000699	0.00227	CcSEcCtD
Auranofin—Anaemia—Docetaxel—pancreatic cancer	0.000692	0.00225	CcSEcCtD
Auranofin—Pancytopenia—Epirubicin—pancreatic cancer	0.000688	0.00224	CcSEcCtD
Auranofin—Vomiting—Sunitinib—pancreatic cancer	0.000682	0.00222	CcSEcCtD
Auranofin—Neutropenia—Epirubicin—pancreatic cancer	0.000678	0.0022	CcSEcCtD
Auranofin—Rash—Sunitinib—pancreatic cancer	0.000677	0.0022	CcSEcCtD
Auranofin—Dermatitis—Sunitinib—pancreatic cancer	0.000676	0.0022	CcSEcCtD
Auranofin—Urticaria—Fluorouracil—pancreatic cancer	0.000673	0.00219	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—pancreatic cancer	0.000671	0.00218	CcSEcCtD
Auranofin—Leukopenia—Docetaxel—pancreatic cancer	0.00067	0.00218	CcSEcCtD
Auranofin—Eosinophilia—Doxorubicin—pancreatic cancer	0.000664	0.00216	CcSEcCtD
Auranofin—Weight decreased—Epirubicin—pancreatic cancer	0.000656	0.00213	CcSEcCtD
Auranofin—Nausea—Sunitinib—pancreatic cancer	0.000637	0.00207	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—pancreatic cancer	0.000637	0.00207	CcSEcCtD
Auranofin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000633	0.00206	CcSEcCtD
Auranofin—Stomatitis—Epirubicin—pancreatic cancer	0.00063	0.00205	CcSEcCtD
Auranofin—Jaundice—Epirubicin—pancreatic cancer	0.00063	0.00205	CcSEcCtD
Auranofin—Conjunctivitis—Epirubicin—pancreatic cancer	0.000628	0.00204	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—pancreatic cancer	0.000627	0.00204	CcSEcCtD
Auranofin—Haematuria—Epirubicin—pancreatic cancer	0.000616	0.002	CcSEcCtD
Auranofin—Pruritus—Gemcitabine—pancreatic cancer	0.000609	0.00198	CcSEcCtD
Auranofin—Weight decreased—Doxorubicin—pancreatic cancer	0.000607	0.00197	CcSEcCtD
Auranofin—Diarrhoea—Irinotecan—pancreatic cancer	0.000605	0.00197	CcSEcCtD
Auranofin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000603	0.00196	CcSEcCtD
Auranofin—Pruritus—Fluorouracil—pancreatic cancer	0.000599	0.00195	CcSEcCtD
Auranofin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000598	0.00195	CcSEcCtD
Auranofin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000589	0.00192	CcSEcCtD
Auranofin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000586	0.00191	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—pancreatic cancer	0.000583	0.0019	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—pancreatic cancer	0.000583	0.0019	CcSEcCtD
Auranofin—Anorexia—Docetaxel—pancreatic cancer	0.000582	0.00189	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000581	0.00189	CcSEcCtD
Auranofin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000579	0.00188	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—pancreatic cancer	0.00057	0.00185	CcSEcCtD
Auranofin—Vomiting—Irinotecan—pancreatic cancer	0.000562	0.00183	CcSEcCtD
Auranofin—Visual impairment—Epirubicin—pancreatic cancer	0.000559	0.00182	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000558	0.00181	CcSEcCtD
Auranofin—Rash—Irinotecan—pancreatic cancer	0.000557	0.00181	CcSEcCtD
Auranofin—Dermatitis—Irinotecan—pancreatic cancer	0.000557	0.00181	CcSEcCtD
Auranofin—Vomiting—Gemcitabine—pancreatic cancer	0.000547	0.00178	CcSEcCtD
Auranofin—Rash—Gemcitabine—pancreatic cancer	0.000543	0.00177	CcSEcCtD
Auranofin—Dermatitis—Gemcitabine—pancreatic cancer	0.000542	0.00176	CcSEcCtD
Auranofin—Eye disorder—Epirubicin—pancreatic cancer	0.000542	0.00176	CcSEcCtD
Auranofin—Vomiting—Fluorouracil—pancreatic cancer	0.000538	0.00175	CcSEcCtD
Auranofin—Dyspepsia—Docetaxel—pancreatic cancer	0.000538	0.00175	CcSEcCtD
Auranofin—Rash—Fluorouracil—pancreatic cancer	0.000534	0.00174	CcSEcCtD
Auranofin—Dermatitis—Fluorouracil—pancreatic cancer	0.000533	0.00173	CcSEcCtD
Auranofin—Decreased appetite—Docetaxel—pancreatic cancer	0.000531	0.00173	CcSEcCtD
Auranofin—Nausea—Irinotecan—pancreatic cancer	0.000525	0.00171	CcSEcCtD
Auranofin—Constipation—Docetaxel—pancreatic cancer	0.000523	0.0017	CcSEcCtD
Auranofin—Visual impairment—Doxorubicin—pancreatic cancer	0.000517	0.00168	CcSEcCtD
Auranofin—Alopecia—Epirubicin—pancreatic cancer	0.000513	0.00167	CcSEcCtD
Auranofin—Nausea—Gemcitabine—pancreatic cancer	0.000511	0.00166	CcSEcCtD
Auranofin—Nausea—Fluorouracil—pancreatic cancer	0.000503	0.00164	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—pancreatic cancer	0.000502	0.00163	CcSEcCtD
Auranofin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.0005	0.00162	CcSEcCtD
Auranofin—Flatulence—Epirubicin—pancreatic cancer	0.000498	0.00162	CcSEcCtD
Auranofin—Dysgeusia—Epirubicin—pancreatic cancer	0.000495	0.00161	CcSEcCtD
Auranofin—Abdominal pain—Docetaxel—pancreatic cancer	0.000483	0.00157	CcSEcCtD
Auranofin—Alopecia—Doxorubicin—pancreatic cancer	0.000474	0.00154	CcSEcCtD
Auranofin—Anaemia—Epirubicin—pancreatic cancer	0.000467	0.00152	CcSEcCtD
Auranofin—Flatulence—Doxorubicin—pancreatic cancer	0.00046	0.0015	CcSEcCtD
Auranofin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000458	0.00149	CcSEcCtD
Auranofin—Leukopenia—Epirubicin—pancreatic cancer	0.000452	0.00147	CcSEcCtD
Auranofin—Pruritus—Docetaxel—pancreatic cancer	0.000432	0.00141	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—pancreatic cancer	0.000432	0.0014	CcSEcCtD
Auranofin—Leukopenia—Doxorubicin—pancreatic cancer	0.000418	0.00136	CcSEcCtD
Auranofin—Diarrhoea—Docetaxel—pancreatic cancer	0.000418	0.00136	CcSEcCtD
Auranofin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000404	0.00131	CcSEcCtD
Auranofin—Anorexia—Epirubicin—pancreatic cancer	0.000393	0.00128	CcSEcCtD
Auranofin—Vomiting—Docetaxel—pancreatic cancer	0.000389	0.00126	CcSEcCtD
Auranofin—Rash—Docetaxel—pancreatic cancer	0.000385	0.00125	CcSEcCtD
Auranofin—Dermatitis—Docetaxel—pancreatic cancer	0.000385	0.00125	CcSEcCtD
Auranofin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000373	0.00121	CcSEcCtD
Auranofin—Anorexia—Doxorubicin—pancreatic cancer	0.000363	0.00118	CcSEcCtD
Auranofin—Nausea—Docetaxel—pancreatic cancer	0.000363	0.00118	CcSEcCtD
Auranofin—Dyspepsia—Epirubicin—pancreatic cancer	0.000363	0.00118	CcSEcCtD
Auranofin—Decreased appetite—Epirubicin—pancreatic cancer	0.000358	0.00117	CcSEcCtD
Auranofin—Constipation—Epirubicin—pancreatic cancer	0.000352	0.00115	CcSEcCtD
Auranofin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000337	0.0011	CcSEcCtD
Auranofin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000336	0.00109	CcSEcCtD
Auranofin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000331	0.00108	CcSEcCtD
Auranofin—Urticaria—Epirubicin—pancreatic cancer	0.000327	0.00106	CcSEcCtD
Auranofin—Constipation—Doxorubicin—pancreatic cancer	0.000326	0.00106	CcSEcCtD
Auranofin—Abdominal pain—Epirubicin—pancreatic cancer	0.000326	0.00106	CcSEcCtD
Auranofin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000312	0.00101	CcSEcCtD
Auranofin—Urticaria—Doxorubicin—pancreatic cancer	0.000303	0.000985	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000301	0.00098	CcSEcCtD
Auranofin—Pruritus—Epirubicin—pancreatic cancer	0.000292	0.000948	CcSEcCtD
Auranofin—Diarrhoea—Epirubicin—pancreatic cancer	0.000282	0.000917	CcSEcCtD
Auranofin—Pruritus—Doxorubicin—pancreatic cancer	0.00027	0.000877	CcSEcCtD
Auranofin—Vomiting—Epirubicin—pancreatic cancer	0.000262	0.000852	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000261	0.000849	CcSEcCtD
Auranofin—Rash—Epirubicin—pancreatic cancer	0.00026	0.000845	CcSEcCtD
Auranofin—Dermatitis—Epirubicin—pancreatic cancer	0.00026	0.000844	CcSEcCtD
Auranofin—Nausea—Epirubicin—pancreatic cancer	0.000245	0.000796	CcSEcCtD
Auranofin—Vomiting—Doxorubicin—pancreatic cancer	0.000242	0.000788	CcSEcCtD
Auranofin—Rash—Doxorubicin—pancreatic cancer	0.00024	0.000782	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—pancreatic cancer	0.00024	0.000781	CcSEcCtD
Auranofin—Nausea—Doxorubicin—pancreatic cancer	0.000227	0.000737	CcSEcCtD
Auranofin—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000213	0.000736	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—HRAS—pancreatic cancer	0.000212	0.000734	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—STAT3—pancreatic cancer	0.000212	0.000733	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PTEN—pancreatic cancer	0.00021	0.000728	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—PIK3CA—pancreatic cancer	0.00021	0.000728	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—pancreatic cancer	0.00021	0.000727	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—AKT1—pancreatic cancer	0.00021	0.000727	CbGpPWpGaD
Auranofin—IKBKB—Immune System—DTX4—pancreatic cancer	0.000207	0.000716	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGF—pancreatic cancer	0.000204	0.000707	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PPP2R5B—pancreatic cancer	0.000203	0.000702	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PPP2R5B—pancreatic cancer	0.000201	0.000697	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PTEN—pancreatic cancer	0.000201	0.000695	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IFNA1—pancreatic cancer	0.0002	0.000694	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—AKT1—pancreatic cancer	0.000199	0.000688	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—AKT1—pancreatic cancer	0.000195	0.000676	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—HRAS—pancreatic cancer	0.000194	0.000673	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—pancreatic cancer	0.000188	0.000653	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRLHR—pancreatic cancer	0.000188	0.00065	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—pancreatic cancer	0.000187	0.000649	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—AKT1—pancreatic cancer	0.000187	0.000648	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—NRAS—pancreatic cancer	0.000187	0.000646	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IFNA2—pancreatic cancer	0.000186	0.000646	CbGpPWpGaD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000186	0.000644	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PTEN—pancreatic cancer	0.000186	0.000643	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CD—pancreatic cancer	0.000184	0.000639	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CD—pancreatic cancer	0.000181	0.000628	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—pancreatic cancer	0.000181	0.000626	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—pancreatic cancer	0.000181	0.000626	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—pancreatic cancer	0.00018	0.000622	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—pancreatic cancer	0.000179	0.00062	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ZNRF3—pancreatic cancer	0.000176	0.000611	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ACVR1B—pancreatic cancer	0.000176	0.000611	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—pancreatic cancer	0.000174	0.000602	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—pancreatic cancer	0.000173	0.000601	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	0.000172	0.000596	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—PIK3CA—pancreatic cancer	0.000172	0.000595	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pancreatic cancer	0.000171	0.000592	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—pancreatic cancer	0.00017	0.000589	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—pancreatic cancer	0.000166	0.000575	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—NRAS—pancreatic cancer	0.000166	0.000574	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—pancreatic cancer	0.000163	0.000565	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—pancreatic cancer	0.000162	0.000561	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—pancreatic cancer	0.000161	0.000559	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CB—pancreatic cancer	0.000161	0.000557	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—KRAS—pancreatic cancer	0.000161	0.000556	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SSTR3—pancreatic cancer	0.000159	0.000552	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DTX1—pancreatic cancer	0.000159	0.000552	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—pancreatic cancer	0.000159	0.000552	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CB—pancreatic cancer	0.000158	0.000548	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	0.000158	0.000547	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—pancreatic cancer	0.000154	0.000535	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—pancreatic cancer	0.000154	0.000534	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PIK3CA—pancreatic cancer	0.000153	0.000531	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SSTR1—pancreatic cancer	0.000153	0.00053	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—pancreatic cancer	0.000151	0.000523	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PPY—pancreatic cancer	0.00015	0.000519	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—pancreatic cancer	0.000148	0.000514	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SSTR2—pancreatic cancer	0.000147	0.00051	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP3—pancreatic cancer	0.000145	0.000504	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	0.000144	0.000497	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—pancreatic cancer	0.000143	0.000494	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KRAS—pancreatic cancer	0.000143	0.000494	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCKBR—pancreatic cancer	0.000142	0.000492	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—pancreatic cancer	0.000142	0.000492	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—pancreatic cancer	0.000141	0.00049	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—pancreatic cancer	0.00014	0.000486	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—pancreatic cancer	0.000137	0.000475	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PTEN—pancreatic cancer	0.000137	0.000473	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—pancreatic cancer	0.000136	0.000472	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000136	0.00047	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL2L1—pancreatic cancer	0.000134	0.000465	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	0.000134	0.000464	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DTX4—pancreatic cancer	0.000134	0.000463	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GLI1—pancreatic cancer	0.000134	0.000463	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TSC2—pancreatic cancer	0.000133	0.000462	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	0.000132	0.000459	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PIK3CA—pancreatic cancer	0.000131	0.000454	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—pancreatic cancer	0.000131	0.000454	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00013	0.00045	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRP1—pancreatic cancer	0.00013	0.00045	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—TSC2—pancreatic cancer	0.000128	0.000443	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—SRC—pancreatic cancer	0.000127	0.000439	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—pancreatic cancer	0.000125	0.000434	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HEY2—pancreatic cancer	0.000125	0.000433	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—STAT3—pancreatic cancer	0.000124	0.000431	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NRAS—pancreatic cancer	0.000124	0.00043	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GAST—pancreatic cancer	0.000122	0.000423	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—STAT3—pancreatic cancer	0.000122	0.000423	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NRAS—pancreatic cancer	0.000122	0.000422	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NFKBIA—pancreatic cancer	0.000122	0.000421	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CD44—pancreatic cancer	0.000121	0.000421	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—pancreatic cancer	0.000121	0.00042	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—pancreatic cancer	0.000121	0.00042	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—pancreatic cancer	0.000121	0.000418	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD44—pancreatic cancer	0.00012	0.000417	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	0.000118	0.000408	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IFNA1—pancreatic cancer	0.000118	0.000407	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NFKBIA—pancreatic cancer	0.000117	0.000404	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNA1—pancreatic cancer	0.000117	0.000404	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGF—pancreatic cancer	0.000116	0.000403	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SCT—pancreatic cancer	0.000116	0.000401	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HEY1—pancreatic cancer	0.000116	0.000401	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—pancreatic cancer	0.000116	0.0004	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGF—pancreatic cancer	0.000112	0.000387	CbGpPWpGaD
Auranofin—ALB—Metabolism—PRSS1—pancreatic cancer	0.000111	0.000386	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—pancreatic cancer	0.000111	0.000385	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCK—pancreatic cancer	0.000111	0.000383	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IFNA2—pancreatic cancer	0.000109	0.000379	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNA2—pancreatic cancer	0.000109	0.000376	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CNR2—pancreatic cancer	0.000108	0.000373	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GLP1R—pancreatic cancer	0.000108	0.000373	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—pancreatic cancer	0.000107	0.000371	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—pancreatic cancer	0.000107	0.00037	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCKAR—pancreatic cancer	0.000106	0.000367	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—pancreatic cancer	0.000105	0.000363	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDH1—pancreatic cancer	0.000104	0.00036	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CD—pancreatic cancer	0.000103	0.000358	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JAG2—pancreatic cancer	0.000103	0.000356	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	0.000103	0.000356	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MEN1—pancreatic cancer	0.000101	0.000351	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CD—pancreatic cancer	9.93e-05	0.000344	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—pancreatic cancer	9.8e-05	0.00034	CbGpPWpGaD
Auranofin—ALB—Metabolism—ARG2—pancreatic cancer	9.66e-05	0.000335	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SHH—pancreatic cancer	9.66e-05	0.000335	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—pancreatic cancer	9.64e-05	0.000334	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH4—pancreatic cancer	9.6e-05	0.000333	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IAPP—pancreatic cancer	9.54e-05	0.000331	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTHLH—pancreatic cancer	9.16e-05	0.000317	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTCH1—pancreatic cancer	9.16e-05	0.000317	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—pancreatic cancer	9.07e-05	0.000314	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CB—pancreatic cancer	9.02e-05	0.000312	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—pancreatic cancer	8.92e-05	0.000309	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CB—pancreatic cancer	8.66e-05	0.0003	CbGpPWpGaD
Auranofin—ALB—Metabolism—TYMP—pancreatic cancer	8.45e-05	0.000293	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SST—pancreatic cancer	8.38e-05	0.00029	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	8.23e-05	0.000285	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JAG1—pancreatic cancer	8.2e-05	0.000284	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH3—pancreatic cancer	8.16e-05	0.000283	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	8.02e-05	0.000278	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTNNB1—pancreatic cancer	8e-05	0.000277	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—pancreatic cancer	7.87e-05	0.000273	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2L1—pancreatic cancer	7.81e-05	0.000271	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PTEN—pancreatic cancer	7.79e-05	0.00027	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAU—pancreatic cancer	7.77e-05	0.000269	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TSC2—pancreatic cancer	7.76e-05	0.000269	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CNR1—pancreatic cancer	7.73e-05	0.000268	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTEN—pancreatic cancer	7.48e-05	0.000259	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GCG—pancreatic cancer	7.47e-05	0.000259	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	7.36e-05	0.000255	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—SRC—pancreatic cancer	7.23e-05	0.00025	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AGTR1—pancreatic cancer	7.12e-05	0.000247	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NFKBIA—pancreatic cancer	7.08e-05	0.000245	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STK11—pancreatic cancer	7.02e-05	0.000243	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.97e-05	0.000241	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRAS—pancreatic cancer	6.95e-05	0.000241	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SRC—pancreatic cancer	6.94e-05	0.00024	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CG—pancreatic cancer	6.91e-05	0.000239	CbGpPWpGaD
Auranofin—ALB—Hemostasis—EGF—pancreatic cancer	6.83e-05	0.000237	CbGpPWpGaD
Auranofin—ALB—Metabolism—GLP1R—pancreatic cancer	6.81e-05	0.000236	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGF—pancreatic cancer	6.78e-05	0.000235	CbGpPWpGaD
Auranofin—ALB—Metabolism—DPYD—pancreatic cancer	6.7e-05	0.000232	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRAS—pancreatic cancer	6.68e-05	0.000231	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC2A2—pancreatic cancer	6.36e-05	0.00022	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—pancreatic cancer	6.33e-05	0.000219	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDH1—pancreatic cancer	6.31e-05	0.000219	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.29e-05	0.000218	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	6.26e-05	0.000217	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SMAD4—pancreatic cancer	6.15e-05	0.000213	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—pancreatic cancer	6.08e-05	0.000211	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CD—pancreatic cancer	6.07e-05	0.00021	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.07e-05	0.00021	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CD—pancreatic cancer	6.03e-05	0.000209	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HES1—pancreatic cancer	6e-05	0.000208	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—pancreatic cancer	5.98e-05	0.000207	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—pancreatic cancer	5.75e-05	0.000199	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.53e-05	0.000192	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—pancreatic cancer	5.5e-05	0.00019	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CB—pancreatic cancer	5.29e-05	0.000183	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—pancreatic cancer	5.28e-05	0.000183	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TERT—pancreatic cancer	5.26e-05	0.000182	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CB—pancreatic cancer	5.25e-05	0.000182	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	5.11e-05	0.000177	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—pancreatic cancer	5.09e-05	0.000176	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HIF1A—pancreatic cancer	5.03e-05	0.000174	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TSC2—pancreatic cancer	5.02e-05	0.000174	CbGpPWpGaD
Auranofin—ALB—Metabolism—CD44—pancreatic cancer	4.92e-05	0.000171	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOE—pancreatic cancer	4.91e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—pancreatic cancer	4.88e-05	0.000169	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.82e-05	0.000167	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KDR—pancreatic cancer	4.81e-05	0.000167	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.78e-05	0.000165	CbGpPWpGaD
Auranofin—ALB—Metabolism—GCG—pancreatic cancer	4.72e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTNNB1—pancreatic cancer	4.66e-05	0.000161	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NFKBIA—pancreatic cancer	4.58e-05	0.000159	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTEN—pancreatic cancer	4.54e-05	0.000157	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH1—pancreatic cancer	4.53e-05	0.000157	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—pancreatic cancer	4.49e-05	0.000156	CbGpPWpGaD
Auranofin—ALB—Metabolism—STK11—pancreatic cancer	4.44e-05	0.000154	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CG—pancreatic cancer	4.43e-05	0.000154	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGF—pancreatic cancer	4.38e-05	0.000152	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—pancreatic cancer	4.31e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SRC—pancreatic cancer	4.24e-05	0.000147	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SRC—pancreatic cancer	4.21e-05	0.000146	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.16e-05	0.000144	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—pancreatic cancer	4.13e-05	0.000143	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NRAS—pancreatic cancer	4.08e-05	0.000141	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—pancreatic cancer	4.06e-05	0.000141	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRAS—pancreatic cancer	4.05e-05	0.00014	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CD—pancreatic cancer	3.9e-05	0.000135	CbGpPWpGaD
Auranofin—ALB—Metabolism—TYMS—pancreatic cancer	3.82e-05	0.000132	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—pancreatic cancer	3.79e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—pancreatic cancer	3.69e-05	0.000128	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—pancreatic cancer	3.51e-05	0.000122	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—pancreatic cancer	3.49e-05	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CB—pancreatic cancer	3.4e-05	0.000118	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—pancreatic cancer	3.26e-05	0.000113	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—pancreatic cancer	3.23e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—pancreatic cancer	3.2e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—pancreatic cancer	3.12e-05	0.000108	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—pancreatic cancer	3.12e-05	0.000108	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOE—pancreatic cancer	3.1e-05	0.000108	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—pancreatic cancer	3.04e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNB1—pancreatic cancer	3.01e-05	0.000104	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—pancreatic cancer	2.99e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—pancreatic cancer	2.96e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—pancreatic cancer	2.95e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.94e-05	0.000102	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTEN—pancreatic cancer	2.93e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CG—pancreatic cancer	2.8e-05	9.7e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SRC—pancreatic cancer	2.72e-05	9.43e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—pancreatic cancer	2.7e-05	9.37e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—pancreatic cancer	2.65e-05	9.18e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—pancreatic cancer	2.64e-05	9.13e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—pancreatic cancer	2.62e-05	9.09e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRAS—pancreatic cancer	2.62e-05	9.07e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—pancreatic cancer	2.62e-05	9.06e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CD—pancreatic cancer	2.46e-05	8.53e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—pancreatic cancer	2.44e-05	8.45e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—pancreatic cancer	2.43e-05	8.43e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—pancreatic cancer	2.39e-05	8.26e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—pancreatic cancer	2.25e-05	7.81e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CB—pancreatic cancer	2.15e-05	7.44e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—pancreatic cancer	2.13e-05	7.37e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—pancreatic cancer	2.07e-05	7.17e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—pancreatic cancer	2e-05	6.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—pancreatic cancer	1.92e-05	6.64e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTEN—pancreatic cancer	1.85e-05	6.43e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—pancreatic cancer	1.69e-05	5.86e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—pancreatic cancer	1.31e-05	4.53e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—pancreatic cancer	1.07e-05	3.7e-05	CbGpPWpGaD
